SURG
Get informed when a big investor buys or sells
+ FollowUndervalued by 656.9% based on the discounted cash flow analysis.
| Market cap | $12.42 Million |
|---|---|
| Enterprise Value | $25.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.8 |
| Beta | 0.2 |
| Outstanding Shares | 23,703,775 |
| P/E Ratio | -0.35 |
|---|---|
| PEG | -0.6 |
| Price to Sales | 0.26 |
| Price to Book Ratio | -0.26 |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | -0.67 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.61 |
| Debt to Equity | -0.65 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 10.97%▲ 0.58% |
|---|---|
| Total Invested | $1.68M▼ 51.35% |
| Investors Holding | 33▲ 2.00% |
No data